Candidiasis Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global Candidiasis Market is estimated to be valued at US$ 984.80 Mn in 2023 and is expected to exhibit a CAGR of 3.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview: 

Candidiasis is a fungal infection caused by any type of Candida (a type of yeast). It can cause infections of the mouth, throat, esophagus, lungs, bloodstream, and other parts of the body. Candida infections commonly appear in the mouth or vagina and may cause redness, itching, discharge, burning sensation or other signs and symptoms depending on the infected area of the body.

Market key trends: 

Growing prevalence of HIV/AIDS diseases is a major driver for the Candidiasis market. According to UNAIDS, nearly 37.9 million people were living with HIV/AIDS globally and 770 thousand deaths as a result of AIDS related illnesses in 2018. This weakens the immunity and allows Candida infection to occur easily. Other major trend is the rising adoption of telehealth due to the COVID-19 pandemic. Telehealth enables effective remote monitoring of patients and helps physician determine the severity and manage candidiasis cases without physical examination.

Read More @ https://www.coherentmarketinsights.com/market-insight/candidiasis-market-229

Segment Analysis 

The global Candidiasis market is segmented by drug class into azoles, echinocandins, and polyenes. The azoles segment currently dominates the market due to the wide availability and preference of oral azole medications such as fluconazole for treatment of most Candida infections. The polyenes segment is expected to witness moderate growth owing to high toxicity and other side effects associated with this drug class.

Key Takeaways 

The global Candidiasis market is expected to witness high growth, exhibiting a CAGR of 3.2% over the forecast period, due to the increasing prevalence of HIV/AIDS infections and growing number of surgical procedures across the world.

Regional analysis: North America dominated the global Candidiasis market in 2023 due to the presence of major market players and availability of reimbursement in the region. Asia Pacific is anticipated to grow at the fastest rate during the forecast period owing to rising healthcare investments and increase in number of surgical procedures in developing countries like India and China.

Key players: Key players operating in the Candidiasis market are Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy, Bristol Laboratories, Glenmark Pharmaceuticals, Taro Pharmaceuticals and Perrigo among many other local players. The major players are focusing on new product developments as well as adopting expansion strategies to strengthen their global presence.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more